Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.640
-0.030 (-1.80%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Organogenesis Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 211 | 657 | 402 | 537 | 352 | 1,189 | |
Market Cap Growth | -66.05% | 63.40% | -25.09% | 52.51% | -70.37% | 23.61% |
Enterprise Value | 232 | 765 | 416 | 564 | 375 | 1,205 |
Last Close Price | 1.64 | 5.18 | 3.20 | 4.09 | 2.69 | 9.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 32.83 | - | 108.61 | 22.67 | 12.62 |
Forward PE | - | 24.67 | 58.18 | 136.33 | 11.96 | 23.39 |
PS Ratio | 0.46 | 1.17 | 0.84 | 1.24 | 0.78 | 2.54 |
PB Ratio | 1.42 | 1.52 | 1.04 | 1.93 | 1.33 | 4.93 |
P/TBV Ratio | 1.81 | 2.51 | 1.82 | 2.30 | 1.63 | 6.36 |
P/FCF Ratio | 10.13 | - | 96.34 | 81.96 | - | 38.65 |
P/OCF Ratio | 6.60 | - | 28.32 | 17.37 | 14.17 | 19.18 |
PEG Ratio | - | 0.33 | 0.33 | 0.33 | 0.27 | 1.19 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.51 | 1.36 | 0.86 | 1.30 | 0.83 | 2.58 |
EV/EBITDA Ratio | - | 9.55 | 10.78 | 17.80 | 10.62 | 14.40 |
EV/EBIT Ratio | - | 12.43 | 19.32 | 34.55 | 15.25 | 16.52 |
EV/FCF Ratio | 11.13 | - | 99.53 | 86.05 | - | 39.17 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.23 | 0.19 | 0.11 | 0.44 | 0.48 | 0.56 |
Debt / EBITDA Ratio | 4.93 | 0.81 | 0.75 | 2.42 | 2.39 | 1.38 |
Debt / FCF Ratio | 3.21 | - | 10.37 | 18.57 | - | 4.43 |
Net Debt / Equity Ratio | 0.07 | -0.03 | -0.24 | 0.06 | 0.09 | 0.09 |
Net Debt / EBITDA Ratio | -2.15 | -0.17 | -2.40 | 0.54 | 0.67 | 0.27 |
Net Debt / FCF Ratio | 1.00 | 0.56 | -22.17 | 2.59 | -2.63 | 0.73 |
Asset Turnover | 1.06 | 1.03 | 1.01 | 0.95 | 1.01 | 1.27 |
Inventory Turnover | 4.19 | 4.74 | 4.25 | 4.01 | 4.22 | 4.32 |
Quick Ratio | 2.58 | 3.13 | 3.17 | 2.32 | 2.56 | 2.38 |
Current Ratio | 3.52 | 3.62 | 3.69 | 2.80 | 2.97 | 2.74 |
Return on Equity (ROE) | -25.92% | 9.04% | 0.26% | 1.82% | 6.13% | 49.17% |
Return on Assets (ROA) | -4.11% | 7.02% | 2.81% | 2.24% | 3.44% | 12.43% |
Return on Invested Capital (ROIC) | -8.51% | 13.62% | 7.31% | 2.66% | 6.80% | 35.94% |
Return on Capital Employed (ROCE) | -8.20% | 12.30% | 5.10% | 4.30% | 6.60% | 20.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -48.19% | 5.63% | 0.21% | 0.92% | 4.41% | 7.92% |
FCF Yield | 9.88% | -3.72% | 1.04% | 1.22% | -2.57% | 2.59% |
Buyback Yield / Dilution | 1.00% | 1.08% | 0.81% | -0.27% | 0.96% | -20.03% |